The main objective of this study is to investigate the long-term effects, 3 years after the end of a 2-year pulmonary rehabilitation program with three weekly 1-h exercise sessions and 32 h of education in patients with chronic obstructive pulmonary disease. The method consists of open prospective observational study with 30 patients. Outcome measures were quality of life (QoL) (St George's Respiratory Questionnaire, SGRQ), physical exercise performance (6-min walking test, 6MWT), self-management abilities, lung function, hospitalization, and self-reported exercise. FEV 1 at baseline was 40.1% of predicted. The participants had statistical and clinical significant decrease in SGRQ (improved QoL) and increase in 6MWT during the program. They maintained the level of health they achieved during the program in the next 3 years, with a stable SGRQ score (−0.5 points, 95% CI −3.8 to 2.6 P = 1.000) and 6MWT (+10 m 95% CI 28 to −4, P = 0.273). Eighty percent of the participants had exercised at least 30 min three times a week from the end of the program to year 5. In conclusion, the participants had maintained their achieved level of health, improved their lung function slightly, and continued to exercise regularly 3 years after the end of the program. Chronic Respiratory Disease 2009; 6: 5-11
Introduction
Pulmonary rehabilitation aims to improve the health of patients with chronic obstructive pulmonary disease (COPD). A recently updated systematic review concluded that the evidence strongly supports respiratory rehabilitation as part of the spectrum of management of patients with COPD. 1 However, there is a lack of studies on the long-term effect over years for pulmonary rehabilitation programs (PRGs).
Studies of PRGs lasting up to 18 months show that effects are mainly maintained throughout the duration of the program. [2] [3] [4] [5] [6] The long-term effect, however, is mostly studied for programs of shorter duration. [7] [8] [9] [10] Some of the studies with shorter dura-tion have found that the achieved benefit was lost or diminished during the follow-up period, 8, 10, 11 whereas others have found that the effect has been maintained up to 18 months. 7, 9 There are still too few data to determine the ideal length of pulmonary rehabilitation and how long the treatment effect persists. 1 In a recent publication, we described the outcome measured over a 2-year PRG with three weekly 1-h exercise sessions and 32 h of education in patients with COPD. 12 The participants significantly improved their quality of life (QoL) and exercise tolerance in the first year, but had no further clinically relevant improvement in the second year. The aim of the present study is to investigate long-term effects 3 years after the end of the program.
Materials and methods
This was an open prospective observational outcome study conducted at an outpatient department in a hospital in Central Norway from January 2000 to January 2003. The trial was performed according to the principles of the Helsinki declaration. 13 All who were asked to participate were informed both orally and in writing, and gave a written consent to participate.
Patients
Inclusion criteria were patients diagnosed with COPD who had a pre-bronchodilator forced expiratory volume in 1 s (FEV 1 ) lower than 75% of predicted, who had the ability to converse and participate in physical activity and had not been hospitalized in the last month. Of the 30 participants, 27 were recruited from local general practitioners and three from the hospital where the intervention took place. All the patients invited agreed to participate in the project.
Interventions
The intervention consisted of 32 h of education and three weekly 1-h exercise sessions over 2 years. Patients were encouraged to continue exercising thereafter, but had no contact with the study until the follow-up assessment.
The intervention is described in detail in a previous publication. 12 In short, the intervention was based on self-management principles and the participants were grouped with 5-7 others. Neither age, sex nor the severity of the disease were considered in the setting up of the groups. The majority of the 32 h of educational sessions were held during the six first weeks. There were information sessions from a medical practitioner, pharmacist, psychologist, occupational therapist, nurse, social worker, physiotherapist, and a clinical nutritional physiologist. They focused on knowledge of the nature and treatment of COPD, coping with breathlessness, symptom perception, coping with triggers for breathlessness, and physical activity/relaxation. The participants received a specially made booklet with a summary of all the lectures at the end of the course. The exercise sessions were guided by a physiotherapist trained in COPD care and consisted of 2 h in gymnasium and 1 h in swimming pool each week. Each session in the gym started with 10 min of mobility of shoulder, neck, and thorax, the next 40 min were aimed at endurance training based on interval training, and the last 10 min were used for stretching and relaxation. In the swimming sessions, the foci were endurance, improved mobility in thorax, mobilization of mucus, and relaxation.
Action plans for self-treatment regarding medication in general and medication and handling of exacerbations were individually adjusted for all participants. Five participants who were current smokers were offered an individual smoking cessation intervention consisting of 16 individual sessions over 6 months.
Outcome measures
The primary outcomes were:
St George's Respiratory Questionnaire (SGRQ), 14 Norwegian version. 15 The SGRQ total score was the primary measurement, but the domains: "symptoms," "activity," and "impact" are also reported. The scores for all scales are weighted to range from 0 to 100, a score of 100 indicating maximum disability. A difference of four units or more indicates a clinically relevant effect. 16 6-min walking test (6MWT) to measure exercise tolerance. 17, 18 The test was done indoors, the walking course was 45 m in length, and the same technician performed all the tests. Verbal cueing was limited to two standardized prompts: "You're half way done" and "You have one minute to go." The 6MWT was done about the same time of the day and administered twice at baseline (practicethe best result used), and once on the other time points. A change of 54 m or more in walking distance is considered clinically relevant. 19 The secondary outcomes were:
Modified Borg scale (MBS) pre, during, and post-6MWT. 18, 20 The highest value, indicating maximum disability, during 6MWT is reported. Borg scale ranges from 0 to 10, where 0 indicates no problem. Breathing Problems Questionnaire short version, 21 Norwegian version 22,23 with 10 items with a possible score between 0 and 30, where 0 indicates no problem. COPD Self-Efficacy scale (CSES). 24 Norwegian short form version (not validated) with 12 questions with a possible score between 0 and 60, where 0 indicates no problem. Pre-bronchodilator FVC (forced vital capacity) percentage predicted and pre-bronchodilator FEV 1 percentage predicted (Spirobank G, Ocèan WinSpiro, Rome, Italy).
Chronic Respiratory Disease

Long-term result of pulmonary rehabilitation A Steinsbekk and BK Lomundal
Arterial saturation (SaO 2 ) (Tuffsat, Datex-Ohmeda, Louisville, USA) during rest. Number of hospitalizations and number of days in hospital due to exacerbations.
To measure whether the participants had continued to exercise after the intervention, the participants were asked 3 years after the end of the intervention, "Have you exercised regularly at least thirty minutes three times a week since the end of the program?" and if "yes" "Have you mainly taken part in organized group exercise or have you mainly exercised on your own?". The participants were informed that walking in the neighborhood for minimum 30 min was an example of an activity that was regarded as exercise. They were also asked to describe the type of exercise.
Analyses
Confirmatory testing of the main outcome measure is based on intention to treat, with all patients who started the study included in the analysis. Missing data for those who died were replaced with the last recorded value carried forward (none was lost to follow-up), as this gave the same results as not including those with missing data. Data were analyzed using descriptive statistics and General Linear Model repeated measurement analysis with Bonferroni confidence interval (CI) adjustment. Mann-Whitney non-parametric exact test was used to analyze differences between those who had continued to exercise or not because of the small numbers. All analyses were done in SPSS for Windows version 14.0.1 (SPSS Inc., Chicago, IL, USA).
Results
A total of 30 patients participated. One patient died during the intervention part of the study (9 months after start) and three during the follow-up period (30, 41 , and 58 months after start). Causes of death were heart failure, cerebral infarct, cerebral hemorrhage, and lung cancer. At baseline, the patients' ages were on average 63 years and 56% were women (Table 1) . They had 40.1% of predicted FEV 1 and 76.6% of predicted FVC ( Table 2) . Their average SGRQ score at baseline was 56.6 and they walked 423 m during 6 min ( Table 2) . All five patients who took part in the smoking cessation program stopped smoking and did not start again during the study time and none smoked at the 5-year follow-up.
Short-term effect
During the 2-year intervention period, the group had a statistical significant and clinical relevant improvement in QoL (improvement in SGRQ total score of −11.2 points, 95% CI −13.9 to −8.4, P < 0.001), and functional exercise performance (increased 6MWT distance of 86 m, 95% CI 63-109, P < 0.001) ( Figure 1 , Table 2 ). There was also a statistically significant improvement (P < 0.001) for Borg score, BPQ, CSES, and the SGRQ subscales. There was no significant change in lung function and hospitalization because of exacerbations from baseline to 2 years, but pre-bronchodilator FEV 1 improved slightly but statistically significantly the first year (P = 0.017). The main improvement for all variables took place during the first year of the intervention. 12 
Long-term effect
The long-term effects were measured about 5 years (57 months, 95% CI 51-63, range 56-68) after the start of the program.
Compared with the situation at the end of the program (year 2), the participants had maintained their HRQoL (SGRQ total −0.5 points, 95% CI −3.1 to 2.0 P = 1.000) 3 years later (year 5) ( Table 2 ). Functional exercise performance measured by 6MWT was non-significantly improved by 10 m (95% CI 23 to −2, P = 0.166). There was a small but statistically significant improvement in FEV 1 in the follow-up period from 40.3% to 41.0% of predicted and in FVC from 77.1% to 77.9% of predicted. The SGRQ subscale activity also showed a statistically significant but not clinically relevant improvement during the follow-up period. For the other variables, there were small and non-significant changes in the follow-up period. Of those participants who were alive at year 5 (N = 26), 21 (80%) self-reported that they had exercised regularly at least 30 min three times a week since the end of the program. Fourteen had taken part in organized training and seven had exercised on their own. Organized group exercise was 1 h of swimming, dancing or endurance training three times per week, either with other patients with COPD or in programs open for everyone. Some took part in more than one of these activities. All who took part in organized training also exercised by walking on their own most days. Self-exercise was mostly walking, but one person biked or used a treadmill and two persons had an individual adjusted program at a health club.
Those who had continued to exercise tended to have better outcomes on all variables and significantly so for SGRQ (mean difference −9.6, 95% CI −17.8 to −1.5, P = 0.028), BPQ (P = 0.001), and Borg (P = 0.015) ( Table 3 ). There was no significant difference in outcome between those who had taken part in organized training (N = 14) and those who had exercised on their own (N = 7) (data not shown). Logistical regression analysis of three different models found that none of the variables 1) at baseline or 2) after the end of the program or 
Figure 1
Changes in total score of St George's Respiratory Questionnaire (SGRQ) and meters walked during 6-min walking test (6MWT).
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3) after 5 years were significantly associated with having exercised or not after the program (data not shown).
Discussion
The participants significantly improved their QoL and exercise tolerance in the first year of the program, but had no further clinically relevant improvement in the second year. 12 The improved health-related QoL and exercise tolerance at the end of the program was maintained through the 3-year follow-up period. Four of five participants (80%) self-reported that they had exercised regularly at least 30 min three times a week in the 3 years since the end of the program. The strength of this study was the length of both the intervention period and the follow-up time and the variety of outcome measures. A major limitation was that it was an observational study with no control group, but as there is a lack of this type of data in the literature, it is a valuable first step to increase the knowledge of the long-term effect of comprehensive programs. Not having, for example, yearly data during the follow-up period is also a limitation, but as the participants have maintained their level of health, it is not likely that data from more time points would have given any more information.
Another limitation is that the measure of exercise during the follow-up period was based on self-report and only asked about adherence globally over the whole period. The answers could thus be biased by the patients' desire to please the investigators. With this in mind, the finding that nearly 80% of the participants had continued to exercise regularly was encouraging and contrary to findings in studies that have found that many participants dropped out during the program or discontinued the activity after the end of the intervention. 9, 25, 26 This study has no data on why this is so, but we have started a qualitative study to explore the mechanisms that might have motivated these patients to exercise regularly. Areas to be explored based on experiences from doing this study is the influence of a comprehensive program in forming new habits, the perceived safety of supervised exercise with the possibility to ask questions, and the influence of the social process of being in the same group over a long period. Furthermore, factors outside the program such as previous exercise experience and social support from family should also be explored.
The type of participants is likely to influence both the adherence to the intervention and the high number who continued to exercise. It has been found Table 3 Outcomes at year 5 for those who had not exercised, exercised on their own, or taken part in organized exercise after the end of the program (years 2-5) that factors such as socio-economic status and health-related QoL are independently associated with level of physical activity, 27 but the patients in this study were similar to patients in other studies. We think that the program itself contributed to the observed adherence as a sense of group support and increased self-confidence is found to be related to adherence. 28 In other words, we think that being in a long lasting and comprehensive program that focuses on self management is likely to increase the group support and sense of success that leads to self confidence.
We have found no other study with the same intervention and follow-up period. The study with the longest follow-up identified had an 8 weeks exercise intervention and 6 years follow-up and found that the effect diminished during the follow-up period, 8 a finding in line with some studies of shorter follow-up periods. 10, 11 Others have found that the effect has been maintained up to 18 months, 7,9 but none of these have 3-year follow-up period as the present study do.
The only statistical significant improvements in the 3-year follow-up period were surprisingly on lung function (FEV 1 and FVC). The magnitude of the changes was not clinically relevant in itself (less than 1% of predicted), but as it is expected that patients with COPD will have a steady decrease in lung function, 29 this is still an interesting finding. The reason for this relative improvement might be due to the better adherence to medication and the high number of participants who continued to exercise. This assumption is strengthened by the fact that the SGRQ subscale activity, which measures whether the respondents get breathless from regular daily activities, also showed an improvement.
There are elements of the program in addition to the exercise that could influence the results. It used action plans that have been shown to be effective in helping patient to adhere to their medication. 30 During the exercise sessions, both strength and endurance were in focus. 31 To increase the intensity and show the participants that they could manage more than they believed, they were encouraged to continue "just a little bit more" when they were short of breath.
Conclusion
The participants in a 2-year PRG with 32 h of education and three weekly exercise sessions had maintained their achieved level of health, improved their lung function slightly, and continued to exercise regularly 3 years after the end of the program.
